Bilcare Ltd

Bilcare Ltd

₹ 62.1 0.16%
29 May 1:50 p.m.
About

Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).

Key Points

Products & Services offered:
a) Pharma Packaging:[1]
Pharma Packaging is available in two broad categories viz., Polymer based Packaging Films and Aluminum based Packaging Foils. Their sub-categories are:
Blister Films
Blister Foils
Lidding Foils
CR Foils
Laminates
b) Global Clinical Supplies and Services:[2]
Company handles domestic and global manufacturing of IMPs and Placebos, Primary
and secondary packaging with various blinding techniques, IWRS, Storage at variable temperatures.

  • Market Cap 146 Cr.
  • Current Price 62.1
  • High / Low 95.4 / 43.5
  • Stock P/E
  • Book Value 211
  • Dividend Yield 0.00 %
  • ROCE 1.22 %
  • ROE -5.73 %
  • Face Value 10.0

Pros

  • Stock is trading at 0.29 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -24.3% over past five years.
  • Promoter holding is low: 30.0%
  • Company has a low return on equity of -8.16% over last 3 years.
  • Contingent liabilities of Rs.45.1 Cr.
  • Earnings include an other income of Rs.15.9 Cr.
  • Working capital days have increased from 69.2 days to 115 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Packaging Industry: Packaging

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
176 178 204 208 256 248 254 246 234 182 190 175 200
165 165 188 194 237 232 240 234 219 169 173 158 208
Operating Profit 10 12 16 13 19 16 14 12 14 13 17 17 -8
OPM % 6% 7% 8% 6% 7% 6% 6% 5% 6% 7% 9% 10% -4%
38 4 34 0 5 3 10 -6 231 3 1 4 9
Interest 21 18 18 16 17 16 16 16 11 19 20 21 23
Depreciation 12 11 9 10 9 9 9 10 9 10 10 11 13
Profit before tax 15 -13 23 -12 -3 -7 -2 -20 225 -13 -13 -10 -35
Tax % 0% -0% -3% 2% -38% 11% -60% 6% 65% 1% 5% -34% 44%
15 -13 23 -11 -3 -6 -3 -19 78 -13 -12 -14 -20
EPS in Rs 4.97 -6.49 9.51 -5.90 -2.48 -2.84 -2.42 -7.98 19.63 -3.36 -3.22 -2.91 -4.63
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
3,547 3,062 2,692 2,603 2,633 2,778 2,997 1,827 623 845 982 747
3,159 2,819 2,506 2,396 2,443 2,617 2,827 1,782 572 784 925 708
Operating Profit 387 243 186 207 190 161 170 45 51 60 57 39
OPM % 11% 8% 7% 8% 7% 6% 6% 2% 8% 7% 6% 5%
-8 24 9 -87 107 297 59 254 45 44 237 16
Interest 167 217 236 151 176 249 283 174 76 69 60 82
Depreciation 148 141 191 164 177 416 378 239 46 39 38 45
Profit before tax 63 -91 -232 -194 -56 -207 -433 -114 -25 -4 196 -72
Tax % 30% -25% 7% 58% -42% 4% -5% 13% 55% -3% 74% 18%
44 -114 -216 -82 -80 -199 -453 -99 -11 -4 50 -59
EPS in Rs 16.81 -48.14 -91.76 -36.04 -35.91 -85.43 -193.28 -43.97 -8.95 -5.35 6.39 -14.11
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -13%
5 Years: -24%
3 Years: 6%
TTM: -24%
Compounded Profit Growth
10 Years: 6%
5 Years: 14%
3 Years: 3%
TTM: -213%
Stock Price CAGR
10 Years: 0%
5 Years: 17%
3 Years: 3%
1 Year: 44%
Return on Equity
10 Years: -35%
5 Years: -39%
3 Years: -8%
Last Year: -6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 24 24 24 24 24 24 24 24 24 24 24 24
Reserves 1,302 1,300 1,073 689 590 376 -93 85 63 52 507 474
2,104 2,146 2,311 2,122 2,014 2,089 2,270 707 677 690 639 756
971 899 933 786 830 913 888 297 300 362 418 314
Total Liabilities 4,400 4,368 4,340 3,620 3,457 3,402 3,087 1,112 1,064 1,127 1,588 1,568
1,493 2,126 1,926 2,432 2,403 2,180 2,005 534 494 465 1,045 1,039
CWIP 846 262 218 161 149 170 79 0 0 1 1 1
Investments 0 0 0 1 0 1 0 0 0 0 2 8
2,061 1,979 2,196 1,026 904 1,051 1,003 577 570 661 539 521
Total Assets 4,400 4,368 4,340 3,620 3,457 3,402 3,087 1,112 1,064 1,127 1,588 1,568

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
227 314 -315 177 300 98 206 256 72 41 -7 62
-966 -351 247 -358 -129 -203 -104 1,309 2 -4 36 -106
661 48 119 149 -155 91 -103 -1,600 -83 -55 -19 36
Net Cash Flow -78 12 50 -32 16 -13 -1 -35 -9 -18 10 -7

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 106 105 125 35 29 38 38 22 90 95 70 73
Inventory Days 80 103 105 108 84 90 82 28 90 83 43 77
Days Payable 90 76 93 86 81 102 71 35 93 102 79 70
Cash Conversion Cycle 95 132 137 57 32 25 49 15 88 76 33 80
Working Capital Days 130 145 156 35 16 24 28 27 67 57 36 115
ROCE % 8% 3% 1% 2% 2% -8% -6% -9% 3% 3% 3%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01% 30.01%
0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04% 0.04%
69.94% 69.94% 69.94% 69.95% 69.94% 69.94% 69.95% 69.95% 69.95% 69.94% 69.95% 69.95%
No. of Shareholders 21,67021,87021,92822,32223,15823,23623,41922,32221,69119,87519,18119,116

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents